170 related articles for article (PubMed ID: 71207)
21. Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Miller TP; Dana BW; Weick JK; Jones SE; Coltman CA; Dahlberg S; Fisher RI
Semin Hematol; 1988 Apr; 25(2 Suppl 2):17-22. PubMed ID: 2456619
[TBL] [Abstract][Full Text] [Related]
22. Non-Hodgkin's lymphomas-present status of chemotherapy.
Young CW
Clin Bull; 1975; 5(1):20-3. PubMed ID: 776444
[No Abstract] [Full Text] [Related]
23. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
[No Abstract] [Full Text] [Related]
24. Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease.
Koza I; Bohunický L; Mociková K; Gyárfás J; Svancárová L; Mardiak J; Spánik S; Fuchsberger P; Thalmeinerová Z; Sufliarsky J
Neoplasma; 1991; 38(6):583-93. PubMed ID: 1722564
[TBL] [Abstract][Full Text] [Related]
25. Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination.
Young RC; Johnson RE; Canellos GP; Chabner BA; Brereton HD; Berard CW; DeVita VT
Cancer Treat Rep; 1977 Sep; 61(6):1153-9. PubMed ID: 332349
[TBL] [Abstract][Full Text] [Related]
26. Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study.
Weick JK; Jones SE; Haut A; Fisher R; Dixon D
Cancer Treat Rep; 1981; 65(7-8):611-4. PubMed ID: 6166373
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
28. Team approach to management of non-Hodgkin's lymphomas: past and present.
Fuller LM; Gamble JF; Butler JJ; Sinkovics JG; Wallace S; Martin RG; Gehan EA; Shullenberger CC
Cancer Treat Rep; 1977 Sep; 61(6):1137-48. PubMed ID: 71210
[TBL] [Abstract][Full Text] [Related]
29. [Curative aspects of modern combination chemotherapy in generalized malignant lymphomas].
Viollier AF; Senn HJ
Schweiz Med Wochenschr; 1976 May; 106(22):730-42. PubMed ID: 996491
[TBL] [Abstract][Full Text] [Related]
30. [Clinical aspects and therapy of anaplastic T-zone lymphoma].
Bartels H; Schneider B; Feller AC
Dtsch Med Wochenschr; 1984 Jul; 109(28-29):1112-6. PubMed ID: 6204832
[TBL] [Abstract][Full Text] [Related]
31. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
[TBL] [Abstract][Full Text] [Related]
32. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
[TBL] [Abstract][Full Text] [Related]
33. [Therapy of non-Hodgkin lymphomas with COP and COPP regimens (author's transl)].
Rubio-Félix D; Maicas M; Rubio-Vitaller A; Gil JL; Giralt M; Raichs A
Sangre (Barc); 1977; 22(5B):854-9. PubMed ID: 335544
[No Abstract] [Full Text] [Related]
34. Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas a report of 131 cases.
Parlier Y; Gorin NC; Najman A; Stachowiak J; Duhamel G
Cancer; 1982 Aug; 50(3):401-9. PubMed ID: 7046899
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of non-Hodgkin malignant lymphomas].
Gociu M; Coliţă D; Leahu S; Ciocoiu A; Berceanu S
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(1):1-10. PubMed ID: 6145200
[No Abstract] [Full Text] [Related]
36. Chemotherapy of the non-Hodgkin's lymphomas: the Stanford experience.
Portlock CS; Rosenberg SA
Cancer Treat Rep; 1977 Sep; 61(6):1049-55. PubMed ID: 332344
[No Abstract] [Full Text] [Related]
37. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
38. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E
Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265
[TBL] [Abstract][Full Text] [Related]
40. Therapy of non-Hodgkin's lymphomas in relapse.
Klener P; Donner L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):36-40. PubMed ID: 6157622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]